Final Results - Year Ended 31 Dec 1999, Part 2
Microgen PLC
24 February 2000
PART II
MICROGEN PLC
Group Profit and Loss Account
for the year ended 31 December 1999
Unaudited Audited
Year 14 month
ended ended
31 Dec 31 Dec
1999 1998
Notes £'000 £'000
Turnover
- continuing operations 26,633 35,709
- acquisitions 4,691 -
- discontinued operations - 34,396
------ --------
1 31,324 70,105
Operating costs (30,352) (72,981)
-------- ----------
Operating profit/(loss):
Continuing operations
- adjusted operating
profit/(loss)- including
acquisition 2,958 (3,427)
- re-structuring costs
and surplus property
costs provision (299) (3,520)
-------- --------
Operating profit/(loss)
before goodwill amortisation
and Charges related to
positive share price
movements 2,659 (6,947)
Goodwill amortisation and
charges related to positive
share price movements 4, 5 (1,687) (50)
-------- ---------
Operating profit/(loss) 972 (6,997)
Discontinued operations - 4,121
-------- ---------
Operating profit/(loss) 1 972 (2,876)
Loss on Disposal of
Fixed Assets - (1,552)
continuing operations
Exceptional items - 12,981
-------- -------
972 8,553
Net interest 862 (61)
-------- -------
Profit on ordinary activities
before tax 1,834 8,492
Tax on profit on ordinary
activities 6 (446) (7,569)
------- ---------
Profit on ordinary activities
after taxation 1,388 923
Dividends 2 (762) (435)
------ ---------
Retained profit transferred
to reserves 626 488
------ ---------
Earnings per share (after
goodwill amortisation and
charges related to
positive share price
movements) 3
Basic 2.9p 2.2p
Diluted 2.8p 2.2p
Adjusted earnings per share
(before goodwill
amortisation and charges
related to positive share
price movements) 3
Basic 5.8p 2.2p
Diluted 5.7p 2.2p
Dividend per share 1.5p 1.0p
MICROGEN PLC
Consolidated Balance Sheet
Unaudited Audited
as at 31 as at 31
Dec 1999 Dec 1998
Notes £'000 £'000
Fixed Assets
- Tangible 4,524 5,381
- Intangible 5 24,276 -
- Investment in own shares 5 372 -
------ -------
29,172 5,381
Current assets
- Stocks - raw materials 288 388
- Debtors 4,855 9,641
- Cash at bank and in hand 18,824 26,695
------ --------
23,967 36,724
Creditors: due within one 7(a) (14,056) (16,077)
year ------- --------
Net current assets 9,911 20,647
Total assets less current 39,083 26,028
liabilities
Creditors: due after more 7(b) (1,104) (997)
than one year
Provisions for liabilities (2,438) (2,550)
and charges ------ --------
Net assets 35,541 22,481
====== ========
Equity capital and reserves
- Called up share capital 8 2,543 2,173
- Share premium account 9 16,762 4,748
- Other reserves 9 150 50
- Profit and loss account 9 16,086 15,510
------- -------
Equity Shareholders' funds 35,541 22,481
======= =======
MICROGEN PLC
Consolidated Cash Flow Summary
for the Year Ended 31 December 1999
Unaudited Audited 14
Year months
ended ended
31 Dec 1999 31 Dec 1998
£'000 £'000
Notes
Net cash flow from operating 9 (i) 4,647 5,136
activities
Returns on investments and 839 (163)
servicing of finance
Taxation (5,522) (871)
Capital expenditure and financial (1,001) (3,080)
investment
Acquisitions and disposals (5,658) 22,717
Equity dividends paid to (688) (1,029)
shareholders ------ -------
Cash (outflow)/inflow before use (7,383) 22,710
of liquid resources
Financing (488) (248)
----- ------
(Decrease)/increase in cashin 9(ii) (7,871) 22,462
the period ====== ======
Notes:
1. Turnover and Operating profit/(loss) by division
Unaudited Audited
year 14 months
ended ended
31 Dec 31 Dec
1999 1998
Turnover £'000 £'000
Continuing operations
- Billing services and 26,633 35,709
database management
Acquisition -
- Consultancy 4,691 -
------ -------
31,324 35,709
Discontinued operations - 34,396
------ -------
31,324 70,105
------ -------
Operating profit/(loss)
before group overhead
Continuing operations
- Billing services and 3,692 (2,272)
database management
Acquisition -
- Consultancy 735 -
------ --------
4,427 (2,272)
Group overhead (1,469) (1,155)
Goodwill amortisation - (835)
acquisition
Charges related to positive
share price movements:
Charges related to positive (852) (50)
share price movements
Surplus property provision (299) (2,550)
Restructuring costs - (970)
------ -------
972 (6,997)
Discontinued operations - 4,121
----- --------
Operating profit/(loss) 972 (2,876)
----- --------
2. Final Dividend
The Board recommend a final dividend of 1.0 pence per share
(1998: 1.0 pence) and if approved this will be paid on 12 May
2000 to shareholders on the register on 24 March 2000. The
total dividend for the year will be 1.5 pence per share
(1998: 1.0 pence).
3. Earnings per share
Earnings Basic Diluted
EPS EPS
£'000 Pence Pence
Profit on ordinary activities
after tax 1,388 2.9 2.8
Charges related to positive
share price movements 596 1.2 1.2
(net of tax)
Goodwill amortisation 835 1.7 1.7
----- ---- -----
Profit on ordinary activities
after tax but before goodwill
& Charges related to positive
share price movements 2,819 5.8 5.7
----- ----- -------
The above basic earnings per share calculations are based on
the weighted average number of shares in issue during the
period of 48,275,585 (1998: 41,751,023 ). Diluted earnings
per share calculations are based on 49,428,598
(1998:41,751,023) ordinary shares calculated as the basic
weighted average number of ordinary shares plus 1,092,949
(1998: Nil) dilutive share options. The figures for 1998
have been restated in accordance with FRS 14.
4.
Charges related to positive share price movements
Group operating profit for the year is determined after
charges of £852,000 (1998:£50,000) related to positive share
price movements. These comprise National Insurance
Contributions (NIC) on grant of share options of £672,000,
(1998:£ Nil) and UITF 17 charges of £180,000 (1998:£50,000).
For share options granted on or after 6 April 1999 Employers
NIC are payable on the uplift in share price form the date of
grant to the date of exercise. The Group has made provision
in the accounts for the period for the increase in value of
those share options granted on or after 6 April 1999 to
reflect the increase in share price to 667.5 pence as at 31
December 1999.
5. Acquisition of Kaisha Group
On 29 March 1999 the Company announced the acquisition,
subject to shareholders approval, of the Kaisha Group, a
leading independent business intelligence consultancy.
Shareholders' approval was obtained at an EGM on 22 April
1999 and the acquisition of Kaisha Group was formally
completed on 23 April 1999.
The key financial details in respect of the acquisition are
scheduled below.
Notes £'000
Consideration and costs in
respect of acquisition:
Cash 5,965
Loan Notes 4,600
Ordinary shares 7,615
------
Initial consideration 18,180
Shares issued in respect of (i) 1,048
replacement options
Increase in fair value of (ii) 3,137
consideration
Deferred consideration 2,430
Fees and costs in respect of
the acquisition 885
------
Total consideration and costs 25,680
------
(i) At the time of the transaction the Company established The
Microgen Employee Share Participation Scheme 1999 to facilitate
the issue of replacement options over Microgen plc shares to
Kaisha employees in exchange for their options in Kaisha
Technology Limited. 1,200,000 shares were issued to the MESPS
1999 at £1.25 per share.Options over 838,000 Microgen shares were
issued to Kaisha employees in consideration for their interest in
Kaisha share options with a value of £1,048,000. The balance of
362,000 shares are shown as investment in own shares in the
consolidated balance sheet of the Group. An option over 280,000
shares has been granted to an employee of Kaisha at nil
subscription which are subject to performance criteria. The costs
of these shares is being written off over the three year vesting
period in accordance with UITF 17.
(ii) The increase in fair value of consideration represents the
increase in value of the ordinary shares in Microgen plc between
exchange of contracts for the transaction and completion.
Kaisha Group (at date of
acquisition) Preliminary Provisional Net Assets
Balance Fair Value Acquired
Sheet Adjustment
£'000 £'000 £'000
Fixed assets 378 (37) 341
Debtors 1,495 (52) 1,443
Cash at bank 856 - 856
Creditors (1,151) (277) (1,428)
Taxation (644) - (644)
-------------------------------
Net assets 934 (366) 568
-------------------------------
--------
Goodwill on acquisition 25,112
========
The provisional fair value adjustments relate to (i) a reduction
in the net book value of fixed assets to a directors estimate of
their value (£37,000); (ii) adjustment to accounting policies to
bring them in line with those of Microgen plc (£52,000) and (iii)
an accrual in respect of liabilities not recognised in the
preliminary balance sheet (£277,000).
The Goodwill on acquisition has been capitalised in accordance
with FRS 10 and is being amortised over 20 years.
6.
Taxation
The taxation charge for the year comprises:
Unaudited Audited 14
year months
ended ended
31 Dec 31 Dec
1999 1998
£'000 £'000
UK Corporation Tax at 30.25%
(1998:31%) 435 (774)
Tax on profit on disposal of Nordic
and German subsidiaries - 6,488
Overseas Taxation 11 1,855
----- ------
446 7,569
----- ------
The effective rate of tax for the group on its profit on
ordinary activities after tax but before goodwill is 16.8%
(1998:89.1%). At 31 December 1999 the UK group had a
potential deferred tax asset of £1,526,000 (1998:£1,911,000)
due to timing differences relating to accounting provisions,
principally the property provision, and capital allowance
which,in accordance with UK GAAP, has not been recognised in
the accounts. The movement in the deferred tax asset in the
year was £385,000 (1998: £1,810,000) and without this
movement the effective rate of tax would have been 31.3%
(1998:67.8%).
7. Creditors: Unaudited Audited
as at as at
31 Dec 1999 31 Dec 1998
(a) due within one year £'000 £'000
- Bank loans & overdrafts - -
- Finance leases (534) (638)
- Creditors (6,125) (9,154)
- Corporate taxation (481) (5,850)
- Deferred consideration (1,807) -
- Loan Notes (4,600) -
- Proposed dividend (509) (435)
--------- -------
(14,056) (16,077)
--------- ---------
(b) due after more than one year
- Bank loans - -
- Finance leases (481) (997)
- Deferred consideration (623) -
-------- ---------
(1,104) (997)
-------- --------
8. Share Capital
The movement in authorised and issued Ordinary Share Capital
of 5 pence each during the period is detailed below.
Authorised Issued and fully paid
Number Amount Number Amount
At 1 January 1999 61,420,000 £3,071,000 43,469,137 £2,173,457
Increase in
authorised
share capital at
EGM held 8,580,000 £429,000
on 22 April 1999
Shares issued to the
shareholders of the
Kaisha Group 6,091,866 £304,593
Shares issued to the
Microgen Employee Share
Participation Trustees
Limited 1,200,000 £60,000
Issued under savings
related option schemes 94,009 £4,700
---------------------------------------------
At 31 December1999 70,000,000 £3,500,000 50,855,012 £2,542,750
----------------------------------------------
9. Movement on reserves
Share ----Profit and Loss Account---
Premium Other Revenue Goodwill
Account reserves Reserve Reserve Total
£'000 £'000 £'000 £'000 £'000
At 1 January
1999 4,748 50 27,254 (11,744)15,510
Retained profit
for the period 626 626
Exchange rate (50) (50)
adjustments
Shares issued 12,014
during the period
Charges related to 100
positive share
price movements
----------------------------------------------
At 31 December 16,762 150 27,830 (11,744) 16,086
1999 ----------------------------------------------
10. Notes to the Consolidated Cash Flow Statement
(i) Reconciliation of operating profit/(loss) to net cash
inflow from operating activities
Unaudited Audited14
year months
ended ended 31
31 Dec1999 Dec 1998
£'000 £'000
Operating profit/(loss) 972 (2,876)
Depreciation 2,305 6,283
(Profit)/loss on sale of (106) 236
fixed assets
Other non-cash movements 1,687 50
Decrease/(increase) in stocks 100 220
Decrease/(increase) in debtors 5,292 (2,466)
(Decrease)/increase in creditors (5,603) 3,689
------- -------
Net cash inflow from 4,647 5,136
operating activities ======= =======
Other non-cash movements relate to goodwill amortisation and
charges arising from positive share price movements.
(ii)Reconciliation of net cash flow to movement in
funds/(debt)
Unaudited Audited 14
year months
ended ended
31 Dec 31 Dec
1999 1998
£'000 £'000
(Decrease)/Increase in cash in the (7,871) 22,462
period
Cash outflow from decrease in debt - 3,000
Cash outflow from decrease in
lease financing 620 845
------- -------
Change in net funds/(debt) (7,251) 26,307
resulting from cash flows
Issue of loan note (4,600) -
New finance leases - (131)
Translation difference - 264
------- --------
Movement in net funds/(debt) (11,851) 26,440
in the period
Net funds/(debt) at beginning
of the period 25,060 (1,380)
-------- --------
Net funds/(debt) at end of period 13,209 26,060
======== ========
iii) Analysis of net funds
Other
At Non
Cash
1 Jan Cash Changes 31 Dec 1999
1999 Flow
£'000 £'000 £'000 £'000
Cash at bank and in 26,695 (7,871) - 18,824
hand
Debt due within 1 year - - (4,600) (4,600)
Finance leases (1,635) 620 - (1,015)
----------------------------------
Total 25,060 (7,251) (4,600) 13,209
-----------------------------------
11. Statement by the directors
The figures in the consolidated Profit and Loss Account and
Balance Sheet do not amount to full accounts within the
meaning of Section 254 of the Companies Act 1985.
The Annual Report for the period ended 31 December 1999 will
be posted to shareholders in due course and will also be
available on the investor relations page of our web site
(www.microgen.co.uk). Further copies will be available on
request and free of charge from the Company Secretary at 11
Park Street, Windsor, Berkshire SL4 1LU.